U.S. flag

An official website of the United States government

NM_000133.4(F9):c.1345C>T (p.Arg449Trp) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 16, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003230584.8

Allele description [Variation Report for NM_000133.4(F9):c.1345C>T (p.Arg449Trp)]

NM_000133.4(F9):c.1345C>T (p.Arg449Trp)

Gene:
F9:coagulation factor IX [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq27.1
Genomic location:
Preferred name:
NM_000133.4(F9):c.1345C>T (p.Arg449Trp)
HGVS:
  • NC_000023.11:g.139562030C>T
  • NG_007994.1:g.36295C>T
  • NM_000133.4:c.1345C>TMANE SELECT
  • NM_001313913.2:c.1231C>T
  • NP_000124.1:p.Arg449Trp
  • NP_000124.1:p.Arg449Trp
  • NP_001300842.1:p.Arg411Trp
  • LRG_556t1:c.1345C>T
  • LRG_556:g.36295C>T
  • LRG_556p1:p.Arg449Trp
  • NC_000023.10:g.138644189C>T
  • NM_000133.3:c.1345C>T
Protein change:
R411W
Links:
dbSNP: rs757996262
NCBI 1000 Genomes Browser:
rs757996262
Molecular consequence:
  • NM_000133.4:c.1345C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001313913.2:c.1231C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003928799Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Apr 16, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Hemophilia B is a quasi-quantitative condition with certain mutations showing phenotypic plasticity.

Chavali S, Ghosh S, Bharadwaj D.

Genomics. 2009 Dec;94(6):433-7. doi: 10.1016/j.ygeno.2009.08.005. Epub 2009 Aug 19.

PubMed [citation]
PMID:
19699296

Analysis of F9 point mutations and their correlation to severity of haemophilia B disease.

Hamasaki-Katagiri N, Salari R, Simhadri VL, Tseng SC, Needlman E, Edwards NC, Sauna ZE, Grigoryan V, Komar AA, Przytycka TM, Kimchi-Sarfaty C.

Haemophilia. 2012 Nov;18(6):933-40. doi: 10.1111/j.1365-2516.2012.02848.x. Epub 2012 May 29.

PubMed [citation]
PMID:
22639855
See all PubMed Citations (8)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003928799.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

Variant summary: F9 c.1345C>T (p.Arg449Trp) results in a non-conservative amino acid change located in the Serine proteases, trypsin domain (IPR001254) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.3e-05 in 182873 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1345C>T has been reported in the literature as detected among cohorts of patients with Haemophilia B in the Haemophilia B database with some reports indicating it is non-causative/mild/not severe (example, Giannelli_1994, Wulff_1995, Montejo_1999, Jenkins_2008, Chavali_2009, Hamasaki-Katagiri_2012, Johnsen_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Factor IX Deficiency (Hemophilia B). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024